Clinical and Translational Operations

The Clinical and Translational Operations team at FogPharma is responsible for designing and executing clinical trials that evaluate the safety and efficacy of the company's innovative cell-penetrating miniproteins (CPMPs). This team collaborates closely with cross-functional partners to ensure seamless integration of translational research into clinical development, facilitating the transition of groundbreaking therapies from the lab to the clinic while addressing regulatory requirements and optimizing patient outcomes. Their efforts are crucial in advancing FogPharma's mission to target previously "undruggable" diseases.